CoChat

The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring

Open access
Batool, Syeda Maheen, Yekula, Anudeep, Khanna, Prerna, Hsia, Tiffaney, Gamblin, Austin S., Ekanayake, Emil, Escobedo, Ana K., You, Dong Gil, Castro, Cesar M., Im, Hyungsoon, Kilic, Tugba, Garlin, Michelle Andrea, Skog, Johan, Dinulescu, Daniela M., Dudley, Jonathan, Agrawal, Nishant, Cheng, Jordan, Abtin, Fereidoun, Aberle, Denise R., Chia, David, Elashoff, David, Grognan, Tristan, Krysan, Kostyantyn, Oh, Scott S., Strom, Charles, Tu, Michael, Wei, Fang, Xian, Rena R., Skates, Steven J., Zhang, David Y., Trinh, Thi, Watson, Mark, Aft, Rebecca, Rawal, Siddarth, Agarwal, Ashutosh, Kesmodel, Susan B., Yang, Changhuei, Shen, Cheng, Hochberg, Fred H., Wong, David T.W., Patel, Abhijit A., Papadopoulos, Nickolas, Bettegowda, Chetan, Cote, Richard J., Srivastava, Sudhir, Lee, Hakho, Carter, Bob S., Balaj, Leonora · 2023 · Cell Reports Medicine
Cited by 213

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The emerging field of liquid biopsy stands at the forefront of novel diagnostic strategies for cancer and other diseases. Liquid biopsy allows minimally invasive molecular characterization of cancers for diagnosis, patient stratification to therapy, and longitudinal monitoring. Liquid biopsy strategies include detection and monitoring of circulating tumor cells, cell-free DNA, and extracellular vesicles. In this review, we address the current understanding and the role of existing liquid-biopsy-based modalities in cancer diagnostics and monitoring. We specifically focus on the technical and clinical challenges associated with liquid biopsy and biomarker development being addressed by the Liquid Biopsy Consortium, established through the National Cancer Institute. The Liquid Biopsy Consortium has developed new methods/assays and validated existing methods/technologies to capture and characterize tumor-derived circulating cargo, as well as addressed existing challenges and provided recommendations for advancing biomarker assays.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xcrm.2023.101198

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Metadata

Authors
Batool, S. M., Yekula, A., Khanna, P., Hsia, T., Gamblin, A. S., Ekanayake, E., Escobedo, A. K., You, D. G., Castro, C. M., Im, H., Kilic, T., Garlin, M. A., Skog, J., Dinulescu, D. M., Dudley, J., Agrawal, N., Cheng, J., Abtin, F., Aberle, D. R., Chia, D., Elashoff, D., Grognan, T., Krysan, K., Oh, S. S., Strom, C., Tu, M., Wei, F., Xian, R. R., Skates, S. J., Zhang, D. Y., Trinh, T., Watson, M., Aft, R., Rawal, S., Agarwal, A., Kesmodel, S. B., Yang, C., Shen, C., Hochberg, F. H., Wong, D. T. W., Patel, A. A., Papadopoulos, N., Bettegowda, C., Cote, R. J., Srivastava, S., Lee, H., Carter, B. S., & Balaj, L.
Venue
Cell Reports Medicine
Publisher
Elsevier BV
Published
2023-10
Volume
4
Issue
10
Pages
101198
ISSN
2666-3791 (ISSN-L)
OpenAlex
W4386769281
Cited by
213
References
7
FWCI
20.67
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. https://app.cochat.ai/papers/10.1016/j.xcrm.2023.101198
The paper
Batool, S. M., Yekula, A., Khanna, P., Hsia, T., Gamblin, A. S., Ekanayake, E., Escobedo, A. K., You, D. G., Castro, C. M., Im, H., Kilic, T., Garlin, M. A., Skog, J., Dinulescu, D. M., Dudley, J., Agrawal, N., Cheng, J., Abtin, F., Aberle, D. R., . . . Balaj, L. (2023). The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2023.101198

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.